Feng Chi Biotech Corp. (6744.TWO)
TWD 19.7
(0.0%)
TWD 19.7
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 22.79 Million TWD | -7.4% |
| 2022 | 24.61 Million TWD | 6.39% |
| 2021 | 23.13 Million TWD | -8.89% |
| 2020 | 25.39 Million TWD | 46.29% |
| 2019 | 17.35 Million TWD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | 4.89 Million TWD | 0.0% |
| 2024 Q1 | 4.89 Million TWD | 3.25% |
| 2023 Q4 | 4.74 Million TWD | 0.0% |
| 2023 FY | 22.79 Million TWD | -7.4% |
| 2023 Q3 | 4.74 Million TWD | -28.68% |
| 2023 Q2 | 6.65 Million TWD | 0.0% |
| 2023 Q1 | 6.65 Million TWD | 23.08% |
| 2022 Q4 | 5.4 Million TWD | 0.0% |
| 2022 FY | 24.61 Million TWD | 6.39% |
| 2022 Q3 | 5.4 Million TWD | 0.0% |
| 2021 FY | 23.13 Million TWD | -8.89% |
| 2020 FY | 25.39 Million TWD | 46.29% |
| 2019 FY | 17.35 Million TWD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Bio Preventive Medicine Corp. | -73.28 Million TWD | 131.1% |
| Genomics BioSci & Tech. Co.,Ltd. | -168.06 Million TWD | 113.561% |
| Advagene Biopharma Co., Ltd. | -92.11 Million TWD | 124.744% |
| Taiwan Bio Therapeutics Co., Ltd | -217.51 Million TWD | 110.479% |
| NaviFUS Corp. | -65.72 Million TWD | 134.676% |
| G&E Herbal Biotechnology Co., Ltd. | 72.4 Million TWD | 68.519% |
| TaiRx, Inc. | -212.29 Million TWD | 110.736% |
| Sinew Pharma Inc. | -170.92 Million TWD | 113.335% |
| Lin BioScience, Inc. | -687.19 Million TWD | 103.317% |
| TaiwanJ Pharmaceuticals Co., Ltd. | -6.04 Million TWD | 476.914% |
| Lumosa Therapeutics Co., Ltd. | -238.04 Million TWD | 109.575% |
| Anti-Microbial Savior BioteQ Co., Ltd | -51.78 Million TWD | 144.015% |
| SYN-TECH Chem. & Pharm. Co., Ltd. | 251.01 Million TWD | 90.92% |
| AP Biosciences Inc | -339.29 Million TWD | 106.717% |
| Sunmax Biotechnology Co., Ltd. | 625.7 Million TWD | 96.357% |
| RBC Bioscience Corporation | 6.43 Million TWD | -254.463% |
| Syngen Biotech Co.,Ltd. | 274.82 Million TWD | 91.707% |
| EirGenix Inc. | -915.2 Million TWD | 102.49% |
| Enimmune corporation | -223.74 Million TWD | 110.187% |
| Lukas Biomedical Inc. | -47.35 Million TWD | 148.132% |
| BRIM Biotechnology, Inc. | -688.02 Million TWD | 103.313% |
| 3D Global Biotech Inc. | -57.95 Million TWD | 139.33% |
| TaiMed Biologics Inc. | -194.81 Million TWD | 111.7% |
| Mycenax Biotech Inc. | -682.84 Million TWD | 103.338% |
| TCI GENE Inc. | 11.67 Million TWD | -95.254% |
| SynCore Biotechnology Co.,Ltd | -38.17 Million TWD | 159.709% |
| Oneness Biotech Co., Ltd. | -1.31 Billion TWD | 101.736% |
| Eusol Biotech Co.,Ltd. | -51.61 Million TWD | 144.159% |
| NeoCore Technology Co., Ltd. | -64.64 Million TWD | 135.257% |
| TWi Biotechnology, Inc. | -170.68 Million TWD | 113.353% |
| Neith Corporation | -40.03 Million TWD | 156.933% |
| Sunny Pharmtech Inc. | -63.32 Million TWD | 135.995% |
| VBI | -6.6 Million TWD | 445.281% |
| Ever Supreme Bio Technology Co., Ltd | 539.39 Million TWD | 95.775% |
| GeneReach Biotechnology Corp. | -166.27 Million TWD | 113.708% |
| Shine-On BioMedical Co.,Ltd. | -37.16 Million TWD | 161.327% |
| CHO Pharma, Inc. | -306.08 Million TWD | 107.446% |
| Andros Pharmaceuticals Co.,Ltd | -68.15 Million TWD | 133.439% |
| MegaPro Biomedical Co., Ltd | -127.54 Million TWD | 117.869% |
| Visgeneer Inc. | -19.58 Million TWD | 216.351% |
| Greenyn Biotechnology Co., Ltd | 130.66 Million TWD | 82.557% |
| BioLASCO Taiwan Co., Ltd. | 49.74 Million TWD | 54.18% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | -88.08 Million TWD | 125.874% |
| Sagittarius Life Science Corp | -55.03 Million TWD | 141.411% |
| BioGend Therapeutics Co., Ltd. | -156.32 Million TWD | 114.58% |
| GlycoNex Incorporation | -178.36 Million TWD | 112.779% |
| Medigen Biotechnology Corp. | -561.29 Million TWD | 104.061% |
| Pharmosa Biopharm Inc. | 8.45 Million TWD | -169.536% |
| PharmaEngine, Inc. | 274.65 Million TWD | 91.701% |
| Intech Biopharm Corporation | -337.98 Million TWD | 106.743% |
| Taiwan Advance Bio-Pharmaceutical Inc. | -10.68 Million TWD | 313.368% |
| BiOptic Inc. | 37.74 Million TWD | 39.619% |
| TaiGen Biopharmaceuticals Holdings Limited | 136.73 Million TWD | 83.331% |
| Senhwa Biosciences, Inc. | -296.3 Million TWD | 107.692% |
| NatureWise Biotech & Medicals Corporation | 10.12 Million TWD | -125.217% |
| OBI Pharma, Inc. | -1.04 Billion TWD | 102.178% |
| Savior Lifetec Corporation | 30.03 Million TWD | 24.103% |
| Great Novel Therapeutics Biotech & Medicals | -61.54 Million TWD | 137.036% |
| Level Biotechnology Inc. | 62.9 Million TWD | 63.768% |
| Medigen Vaccine Biologics Corporation | -1.15 Billion TWD | 101.965% |
| Meribank Biotech Co., Ltd | -125.34 Million TWD | 118.183% |
| Acepodia, Inc. | -817.31 Million TWD | 102.789% |
| Caliway Biopharmaceuticals Co., Ltd. | -488.45 Million TWD | 104.666% |